TRVI: Trevi Therapeutics Inc Bozor kapitallashuvining daromadga nisbati
Geopolitik to'lqinlanishlar neyroterapiya komponentlari yetkazib berishni buzishi va cheklangan hududlarda sinovlarni to'xtatishi mumkin. P/S trayektoriyasi ushbu omillarning kotirovkalarga ta'sirini tasdiqlaydi, bunda ko'rsatkichi parametr holatini belgilaydi. Trevi Therapeutics (TRVI) dori sintezini tashqi pudratchilarga topshiradi, yo'talga qarshi istiqbolli davolash vositalari esa hozirda tartibga soluvchi organlar tomonidan tasdiqlashning yakuniy bosqichlaridan o'tmoqda.
Trevi Pharma (TRVI) kompaniyasi koʻrsatkichlari kesimi va tahlili
- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Trevi Therapeutics|TRVI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Trevi Corp|TRVI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Trevi Pharma|TRVI - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Trevi Therapeutics|Oraliq likvidlik koeffitsiyenti trevitherapeutics.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
TRVI - Sof foyda|Kompaniya foydasi prognozi Trevi Therapeutics|TRVI - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Trevi Therapeutics Inc|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Trevi Pharma|TRVI - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Trevi Therapeutics|TRVI - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi trevitherapeutics.com|TRVI - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Trevi Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:TRVI - trevitherapeutics.com
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi va bu savdoning har bir birligi uchun to'langan premiumni baholash imkonini beradi. Trevi Therapeutics (TRVI) kompaniyasining joriy P/S koeffitsiyentini tahlil qilish orqali investor asossiz spekulyativ o'sishni aniqlashi mumkin, bu esa juda muhimdir, chunki Haduvio ishlanmasidan kelib chiqqan operatsion zararlar allaqachon narxga kiritilgan va kelajakdagi qiymat klinik sinovlarning muvaffaqiyatiga bog'liq.
Trevi Therapeutics kimlar bilan raqobatlashadi
Kapitalizatsiyaning sotish hajmiga nisbati BIIB|P/S multiplikatori NBIX (Neurocrine Biosciences, Inc.)|Bozor kapitallashuvining daromadga nisbati RGC|Axsome Therapeutics Inc - P/S multiplikatori|Sotuvga nisbatan narx ACADIA Corp|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|vikingtherapeutics.com - Bozor kapitallashuvining daromadga nisbati|SUPN (Supernus) - P/S multiplikatori|P/S multiplikatori Catalyst Pharma|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|HRMY: Narxning sotuvga nisbati|P/S multiplikatori BHVN (Biohaven Ltd.)|amylyx.com (AMLX) - Sotuvga nisbatan narx|PRAX: Kapitalizatsiyaning daromadga nisbati|AVXL - P/S multiplikatori|CBLL (CeriBell Corp) - Kapitalizatsiyaning daromadga nisbati|PRTA: Kapitalizatsiyaning sotish hajmiga nisbati|ALEC (Alector Inc.) - P/S multiplikatori|annexonbio.com (ANNX) - Narx/daromad koeffitsiyenti|P/S multiplikatori OMER|Kapitalizatsiyaning daromadga nisbati Neurogene Inc NGNE|Narxning daromadga nisbati AC Immune Corp ACIU|Narx/daromad koeffitsiyenti Voyager Corp (VYGR)|NMRA: Kapitalizatsiyaning daromadga nisbati|scilexholding.com - Kapitalizatsiyaning sotish hajmiga nisbati|Tevogen Bio (TVGN) - Narxning daromadga nisbati|Alpha Cognition Inc. - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CGTX|Narxning daromadga nisbati IKT|P/S multiplikatori SAVA|Narx/daromad koeffitsiyenti assertiotx.com|Narxning daromadga nisbati Coya Therapeutics COYA|VTGN: Kapitalizatsiya va daromad nisbati|Ovid Rx - P/S multiplikatori|Sotuvga nisbatan narx Acumen Pharmaceuticals, Inc|CRVO (CervoMed Inc.) - Kapitalizatsiyaning daromadga nisbati|Alterity Therapeutics Limited (ATHE) - P/S multiplikatori|Narxning daromadga nisbati Clene Inc|PEPG: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD - Sotuvga nisbatan narx|Annovis Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati GRCE (Grace Therapeutics Inc)|AIFF - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KLTO (Klotho Neurosciences Inc)|NRSN: P/S multiplikatori|Sotuvga nisbatan narx Reviva Pharmaceuticals, Inc. (RVPH)|Kapitalizatsiyaning daromadga nisbati MTVA|Narxning daromadga nisbati NRXS|P/S multiplikatori HSDT|Narx/daromad koeffitsiyenti passagebio.com|Neuphoria Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati NERV|ATHA: Kapitalizatsiyaning daromadga nisbati|addextherapeutics.com - Kapitalizatsiyaning sotish hajmiga nisbati|ALZN: P/S multiplikatori|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Sotuvga nisbatan narx Pasithea KTTA|Narxning daromadga nisbati Cortigent, Inc. (CRGT)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|P/S multiplikatori Cara Therapeutics Inc. CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Kapitalizatsiyaning daromadga nisbati MRNS|P/S multiplikatori NKGen Biotech Inc|Kapitalizatsiyaning daromadga nisbati NRBO (NeuroBo)|Kapitalizatsiyaning sotish hajmiga nisbati SAGE|P/S multiplikatori SNPX (Synaptogenix, Inc.)|Narx/daromad koeffitsiyenti trevena.com (TRVN)|Vigil Neuro - P/S multiplikatori|anewmeds.com (WENA) - Kapitalizatsiyaning daromadga nisbati|Cerevel (CERE) - Narxning daromadga nisbati
